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Summary
Although spider bite is common, most spider 
bites cause minor effects and do not require 
treatment. More significant effects result from 
redback and, less commonly, from funnel-web 
spider bites. Redback spider envenoming causes 
local, radiating and regional pain, sometimes 
associated with local or regional diaphoresis,  
non-specific systemic features, and less  
commonly, other autonomic or neurological 
effects. Antivenom is recommended for severe  
or persistent pain and systemic effects.  
Funnel-web spider envenoming can rapidly cause  
life-threatening effects, but it can be treated 
effectively with antivenom. Envenoming is 
characterised by excessive autonomic activity, 
neuromuscular excitation and pulmonary 
oedema. Clinical effects attributed to suspected 
spider bites such as ulcers, should 
be thoroughly investigated for 
other causes including infectious, 
inflammatory, vascular and 
neoplastic conditions.
Key words: antivenom, envenoming, funnel-web, necrotic 
arachnidism, redback.
(Aust Prescr 2006;29:156–8)
Introduction
Spider bites are a common problem with numerous calls being 
made to poisons information centres annually. There is ongoing 
misinformation about the effects of suspected spider bites, 
because past information has been based on circumstantial 
evidence. A definite spider bite is where there is evidence of 
a spider biting (effects), the spider is seen at the time and it is 
then identified by an expert. In a study of 750 definite spider 
bites the majority caused only minor effects and did not 
require treatment in a healthcare facility. Moderate to severe 
envenoming resulted almost exclusively from redback spiders 
and rarely funnel-web spiders.1 Pain or discomfort occurs in all 
spider bites. Other local effects include fang marks or bleeding 
(larger spiders), erythema or red marks (about two-thirds of 
cases) and itchiness. 
Spider bites are best considered in three medically relevant 
groups: big black spiders, redback spiders and all other spiders. 
Big black spiders are any large black-looking spiders that may 
be a funnel-web spider. Patients bitten by big black spiders 
must be managed as having suspected funnel-web spider 
bites until there are no signs of envenoming after four hours. 
Redback spiders are fairly easy to identify and their bites do not 
cause rapidly developing or life-threatening effects but many 
cause significant pain and systemic effects. All other spiders in 
Australia cause minor effects. If the patient has not been bitten 
by a big black spider or a redback spider they can be reassured 
and no further treatment is required. 
Necrotic arachnidism and white-tail spider bite
Necrotic arachnidism, or more commonly in Australia white-tail 
spider bite, has become an entrenched diagnosis despite the 
lack of evidence that spider bites cause 
necrosis or ulcers in Australia. In a 
prospective study of definite white-tail 
spider bites there were no cases of necrotic 
ulcers. The bites caused pain in only 21% of 
patients, pain and a red mark for 24 hours 
in 35%, or a persistent red mark and associated itchiness, pain 
or lump lasting for about seven days in 44%.2 Current evidence 
suggests that spider bites are very unlikely to cause necrotic 
lesions and such cases presenting as suspected spider bites 
should be thoroughly investigated for other causes. A recent 
series of suspected white-tail spider bites found other causes 
when appropriately investigated.3
It is important to distinguish patients presenting with clinical 
effects (usually skin lesions or ulcers) that have been attributed 
to a spider bite and patients with a clear history of a definite 
spider bite. Diagnosis and investigation in patients with ulcers 
must focus on important causes of necrotic ulceration including 
infectious, inflammatory, vascular and neoplastic conditions.3 
Spider bites are very 
unlikely to cause  
necrotic lesions
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Redback spider bites
Redback spider bites are the commonest cause of significant 
envenoming in Australia. Severe and persistent pain occurs 
in a half to two-thirds of cases and may be severe enough to 
prevent sleep in about a third of cases.4 Redback spiders live in 
dry or dark areas and commonly cause bites when people put 
on shoes or when they move outdoor furniture, bike helmets, 
firewood or pot plants. Most bites are by the larger female 
spider and in most cases the spider is recognised by the patient 
if it is seen. Redback spider bites occur in the warmer months 
and peak between January and April.
Envenoming by redback spiders is characterised by local, 
radiating and regional pain which may be associated with 
local and regional diaphoresis, non-specific systemic features, 
and less commonly other autonomic or neurological effects 
(see box). The bite may not be felt or may only be an initial 
irritation or discomfort. Pain increases over about an hour 
and may radiate proximally to the limb or less commonly the 
trunk. These spiders are small and rarely leave fang marks or 
cause local bleeding. Local erythema is common and local 
diaphoresis occurs in about a third of cases. Common non-
specific effects include nausea, lethargy, malaise and headache. 
Numerous other systemic effects are reported less commonly 
(see box). The effects last about 1–4 days with almost all cases 
resolving within one week. There have been no deaths since 
the 1950s. The diagnosis is based on the history, but can be 
difficult in young children and infants who may present with 
undifferentiated pain or distress.
Treatment
There has been controversy over the management of redback 
spider bites, particularly who should be treated with antivenom 
and the route of administration. Pressure bandaging is 
contraindicated in redback spider bites. A recent prospective 
study has suggested that many patients would benefit from 
antivenom treatment because untreated patients had persistent 
pain and many were unable to sleep because of it.4 Although 
intramuscular antivenom has been recommended and used 
for over 40 years there are concerns that it is less effective than 
intravenous antivenom. A recent randomised controlled trial 
was unable to demonstrate a difference between intramuscular 
and intravenous routes, but the trial was small and many 
patients were lost to follow-up.5 A larger ongoing randomised 
controlled trial hopes to determine the more effective route. 
Despite concern about the safety of intravenous antivenom, 
diluted intravenous antivenom appears to have a similar low 
reaction rate to intramuscular antivenom.
Symptomatic relief is probably only effective in the most minor 
cases and even parenteral opiates are ineffective in many cases. 
Antivenom is recommended for systemic envenoming and for 
severe local or radiating pain. The current recommendation 
is an initial dose of two vials of antivenom given as an 
intramuscular injection or as a slow intravenous infusion over 
15 minutes. Intravenous antivenom may be preferred for 
severe envenoming, in children or if there is a poor response 
to intramuscular antivenom. Antivenom has been safely used 
in breast-feeding and pregnant women. The use of antivenom 
24–96 hours after the bites is reasonable based on the natural 
course of envenoming and reported response in these cases.
Adverse effects
Early allergic reactions to redback spider antivenom are rare 
(less than 2%) and premedication is not recommended. Serum 
sickness is uncommon, but all patients should be warned about 
it. For moderate to severe cases of serum sickness a short 
course of prednisone is recommended. Patients who do not 
require treatment with antivenom can be discharged and told to 
return if they require treatment for the pain or systemic effects.
Funnel-web spider bites
Funnel-web spiders (Hexathelidae, Atracinae: Atrax and 
Hadronyche species) are the most dangerous spiders in 
Australia. Severe envenoming has only been reported from 
southern Queensland to southern New South Wales, but it is 
rare (5–10 cases annually requiring antivenom).6 However, 
funnel-web spider envenoming is an important clinical condition 
because of the life-threatening effects, rapid onset and the 
availability of effective antivenom. 
Redback spider bite: clinical effects
Local and regional effects
■ increasing pain at the bite site over minutes to hours, 
which can last for days
■ pain radiating from the bite site to the proximal limb, 
trunk or local lymph nodes
■ local sweating
■ regional sweating with unusual distributions of 
diaphoresis, e.g. bilateral below knee diaphoresis
■ less common effects include piloerection, local erythema, 
fang marks (5%)
Systemic effects
■ nausea, vomiting and headache
■ malaise and lethargy
■ remote or generalised pain
■ abdominal, back or chest pain 
■ less common effects include hypertension, irritability and 
agitation (more common in children), fever, paraesthesia 
or patchy paralysis, muscle spasms, priapism
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Funnel-web spider bites cause immediate local pain, and 
usually puncture marks and local bleeding. In many cases 
this is the only effect because severe envenoming develops in 
only a proportion of cases. In some cases mild envenoming 
occurs with local neurotoxicity (paraesthesia, numbness or 
fasciculations) and/or non-specific systemic effects. Severe 
envenoming is characterised by:
■ autonomic excitation – generalised diaphoresis, 
hypersalivation, lacrimation, piloerection, hypertension, 
bradycardia or tachycardia, miosis or mydriasis
■ neuromuscular excitation – paraesthesia (local, distal and 
oral), fasciculations (local or generalised, commonly tongue 
fasciculations), muscle spasms
■ non-specific systemic effects – abdominal pain, nausea, 
vomiting, headache
■ pulmonary oedema and less commonly myocardial injury
■ central nervous effects – agitation/anxiety, and less 
commonly drowsiness or coma.
Severe envenoming has been reported for six species, including 
the Sydney funnel-web spider (Atrax robustus), the southern 
tree funnel-web spider (Hadronyche cerberea) and northern 
tree funnel-web spider (Hadronyche formidabilis). The Sydney 
funnel-web spider causes severe envenoming in 17% of cases, 
but the two tree funnel-web spiders cause severe envenoming 
in over half of cases.6 
Treatment
First aid for funnel-web spider bite is a pressure immobilisation 
bandage and rapid transport to hospital. The mainstay of 
treatment is funnel-web spider antivenom, admission to a 
critical care area and monitoring for 12–24 hours until all 
evidence of envenoming has resolved. Funnel-web spider 
antivenom appears to be effective in bites by Atrax and 
Hadronyche species. Premedication is not required and early 
allergic reactions and serum sickness are rare.6 The initial dose 
of antivenom is two vials which can be repeated every 15–30 
minutes until envenoming has resolved.
Patients with funnel-web spider bites without symptoms of 
severe envenoming, or bites by unidentified big black spiders 
in eastern Australia, should initially be treated as suspected 
cases of envenoming. These patients should be observed for 
2–4 hours and the pressure immobilisation bandage can be 
removed once funnel-web spider antivenom is available. If 
there is no evidence of severe envenoming after two hours, it 
is unlikely to occur6, but it is prudent to observe the patient for 
four hours.
Mouse spider bites can cause local neurotoxic effects 
(paraesthesia, numbness) and non-specific systemic effects in 
some cases. However, because they are large black spiders, the 
bites should be treated as suspected funnel-web spider bites.
A clinical toxicologist can be contacted for advice on managing 
severe envenoming through the Poisons Information Centre 
(phone 13 11 26). 
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Self-test questions
The following statements are either true or false  
(answers on page 171)
5. Most patients bitten by redback spiders only need 
analgesia and do not require antivenom.
6. Pregnant women should not be given spider antivenom.
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